These observations confirm the role for Bcl-2 family members in cytokine signaling and suggest that IL-7 treatment in combination with other immunotherapies may lead to new clinical strategies to maintain normal T-cell function and reduce tumor induced generation of dysfunctional and suppressor T cells. This evidence concerns the gene IL7 and neoplasm.